However, a wide range of studies have demonstrated that the levels of beta-2-microglobulin in the blood are significantly elevated in patients with renal disease, hematological malignancies, several solid tumors, and autoimmune diseases (discussed in [38]). This evidence concerns the gene B2M and hematologic disorder.